U.S. Physical Therapy (USPH) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does U.S. Physical Therapy (USPH) do?
U.S. Physical Therapy Inc (USPH) is a U.S.-listed company in Healthcare (Medical Care Facilities). What it does: Operates outpatient physical therapy clinics and provides workplace injury prevention services to commercial clients. It partners with local physical therapists who retain a minority ownership stake in outpatient rehabilitation clinics. It is worth $1.41B on the market and sold $838.13M over the last year.
- Market cap
- $1.41B
- P/E ratio
- None (reported a loss)
- Annual sales
- $838.13M
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Brief updated
- Nov 13, 2026
Brands and businesses behind USPH
- Briotix Health: Provides ergonomic consulting and workplace injury prevention to corporations through recurring service contracts.
USPH’s flags, in plain English
Each flag is a number from U.S. Physical Therapy’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.
Still Climbing
Sales up 13.1% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Cheap on Cash Flow
Priced at 20 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.
Pays You to Hold
Pays a 1.95% dividend a year. The company pays part of its profit to shareholders in cash. A dividend can be cut, so it is not guaranteed.
Burning Cash
Losing money, profit margin of -2.4%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
2 more risk notes open with the free trial. Try it free for 7 days.
Questions about USPH
How big is U.S. Physical Therapy?
U.S. Physical Therapy’s market cap is $1.41B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $838.13M: what customers paid the company over the last year, before any costs.
What is USPH’s P/E ratio?
USPH has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with USPH?
Medicare fee schedule cuts regularly reduce reimbursement amounts paid for outpatient therapy procedures. That is one risk on U.S. Physical Therapy’s card. Its first risk flag is Burning Cash, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From U.S. Physical Therapy’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. USPH’s filings on SEC.gov. The Margin Monkey is research, not advice.
